Other Events ·
Nasdaq notifies Genenta Science of non-compliance with the $1.00 minimum bid price
GNTAGenenta Science S.p.A.
Genenta Science S.p.A. received a notification from Nasdaq indicating its American Depositary Shares failed to maintain a closing bid price above $1.00 for 30 consecutive business days between September 3 and October 15, 2026. The company has been granted an initial compliance period of 180 calendar days, ending April 14, 2027, to regain adherence to the minimum bid price requirement. Nasdaq stated the notification does not immediately affect the listing or trading of the ADSs on the Nasdaq Capital Market. To address the deficiency, Genenta may implement a previously approved reverse stock split with a ratio between one-for-ten and one-for-twenty, though no specific effective date has been set. The company operates as a strategic consolidator focused on specialized companies in Italian national security-regulated sectors, including cybersecurity, defense, aerospace, and biotechnology.